Arbutus Biopharma Corp (ABUS) — Cash Flow Reinvestment Rate
Arbutus Biopharma Corp (ABUS) has a Cash Flow Reinvestment Rate of 2.91x as of March 2022, reinvesting $60.06 Million (capex $75.00K plus investments $-59.98 Million) from operating cash flow of $20.62 Million. Check cash flow quality index of Arbutus Biopharma Corp to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Arbutus Biopharma Corp Cash Flow Reinvestment Rate (2012–2012)
Historical reinvestment intensity for Arbutus Biopharma Corp across 1 annual periods. Explore Arbutus Biopharma Corp strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Arbutus Biopharma Corp (2012–2012)
Year-by-year capital reinvestment analysis for Arbutus Biopharma Corp. For live market cap and broader valuation context, see Arbutus Biopharma Corp market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2012 | 0.00x | $14.90K | $33.27 Million | $14.90K | — |